Annual Cash & Cash Equivalents
$751.32 M
+$227.87 M+43.53%
December 31, 2023
Summary
- As of February 7, 2025, RGEN annual cash & cash equivalents is $751.32 million, with the most recent change of +$227.87 million (+43.53%) on December 31, 2023.
- During the last 3 years, RGEN annual cash & cash equivalents has risen by +$34.03 million (+4.74%).
- RGEN annual cash & cash equivalents is now at all-time high.
Performance
RGEN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$783.96 M
-$25.18 M-3.11%
September 30, 2024
Summary
- As of February 7, 2025, RGEN quarterly cash and cash equivalents is $783.96 million, with the most recent change of -$25.18 million (-3.11%) on September 30, 2024.
- Over the past year, RGEN quarterly cash and cash equivalents has increased by +$153.19 million (+24.29%).
- RGEN quarterly cash and cash equivalents is now -3.11% below its all-time high of $809.15 million, reached on June 30, 2024.
Performance
RGEN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RGEN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.5% | +24.3% |
| 3 y3 years | +4.7% | +26.2% |
| 5 y5 years | +287.6% | +52.7% |
RGEN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.5% | -3.1% | +51.8% |
| 5 y | 5-year | at high | +43.5% | -3.1% | +51.8% |
| alltime | all time | at high | >+9999.0% | -3.1% | >+9999.0% |
Repligen Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $783.96 M(-3.1%) |
| Jun 2024 | - | $809.15 M(+3.7%) |
| Mar 2024 | - | $780.62 M(+3.9%) |
| Dec 2023 | $751.32 M(+43.5%) | $751.32 M(+19.1%) |
| Sep 2023 | - | $630.78 M(+4.5%) |
| Jun 2023 | - | $603.66 M(+16.8%) |
| Mar 2023 | - | $516.61 M(-1.3%) |
| Dec 2022 | $523.46 M(-13.3%) | $523.46 M(-8.7%) |
| Sep 2022 | - | $573.36 M(-3.9%) |
| Jun 2022 | - | $596.51 M(+2.0%) |
| Mar 2022 | - | $584.64 M(-3.2%) |
| Dec 2021 | $603.81 M(-15.8%) | $603.81 M(-2.8%) |
| Sep 2021 | - | $621.10 M(-15.4%) |
| Jun 2021 | - | $734.33 M(+3.2%) |
| Mar 2021 | - | $711.32 M(-0.8%) |
| Dec 2020 | $717.29 M(+35.7%) | $717.29 M(+29.6%) |
| Sep 2020 | - | $553.30 M(-1.3%) |
| Jun 2020 | - | $560.36 M(+5.8%) |
| Mar 2020 | - | $529.52 M(+0.2%) |
| Dec 2019 | $528.39 M(+172.6%) | $528.39 M(+2.9%) |
| Sep 2019 | - | $513.45 M(+145.8%) |
| Jun 2019 | - | $208.89 M(+6.5%) |
| Mar 2019 | - | $196.13 M(+1.2%) |
| Dec 2018 | $193.82 M(+11.5%) | $193.82 M(+1.8%) |
| Sep 2018 | - | $190.30 M(+8.4%) |
| Jun 2018 | - | $175.61 M(+1.0%) |
| Mar 2018 | - | $173.88 M(+0.1%) |
| Dec 2017 | $173.76 M(+42.2%) | $173.76 M(+8.8%) |
| Sep 2017 | - | $159.67 M(+12.3%) |
| Jun 2017 | - | $142.21 M(+9.7%) |
| Mar 2017 | - | $129.66 M(+6.1%) |
| Dec 2016 | $122.23 M(+126.0%) | $122.23 M(-22.5%) |
| Sep 2016 | - | $157.65 M(-8.7%) |
| Jun 2016 | - | $172.62 M(+224.4%) |
| Mar 2016 | - | $53.21 M(-1.6%) |
| Dec 2015 | $54.09 M(+53.0%) | $54.09 M(+12.5%) |
| Sep 2015 | - | $48.08 M(+20.2%) |
| Jun 2015 | - | $40.01 M(+28.2%) |
| Mar 2015 | - | $31.21 M(-11.7%) |
| Dec 2014 | $35.36 M(-11.2%) | $35.36 M(-1.5%) |
| Sep 2014 | - | $35.91 M(+6.4%) |
| Jun 2014 | - | $33.76 M(-31.4%) |
| Mar 2014 | - | $49.21 M(+23.6%) |
| Dec 2013 | $39.83 M(+36.4%) | $39.83 M(-5.7%) |
| Sep 2013 | - | $42.24 M(+13.2%) |
| Jun 2013 | - | $37.33 M(+30.7%) |
| Mar 2013 | - | $28.57 M(-2.2%) |
| Dec 2012 | $29.21 M(+161.6%) | $29.21 M(+58.8%) |
| Sep 2012 | - | $18.39 M(+15.8%) |
| Jun 2012 | - | $15.88 M(+24.1%) |
| Mar 2012 | - | $12.79 M(+21.8%) |
| Dec 2011 | $11.17 M(-21.4%) | - |
| Sep 2011 | - | $10.50 M(+40.6%) |
| Jun 2011 | - | $7.47 M(-47.4%) |
| Mar 2011 | $14.20 M(+13.4%) | $14.20 M(+45.0%) |
| Dec 2010 | - | $9.79 M(-35.4%) |
| Sep 2010 | - | $15.16 M(+82.0%) |
| Jun 2010 | - | $8.33 M(-33.5%) |
| Mar 2010 | $12.53 M(+148.5%) | $12.53 M(+135.5%) |
| Dec 2009 | - | $5.32 M(-24.9%) |
| Sep 2009 | - | $7.09 M(+93.0%) |
| Jun 2009 | - | $3.67 M(-27.2%) |
| Mar 2009 | $5.04 M(-84.5%) | $5.04 M(-66.4%) |
| Dec 2008 | - | $14.99 M(-44.7%) |
| Sep 2008 | - | $27.12 M(-18.9%) |
| Jun 2008 | - | $33.46 M(+2.8%) |
| Mar 2008 | $32.56 M(+321.4%) | $32.56 M(+104.5%) |
| Dec 2007 | - | $15.92 M(-58.6%) |
| Sep 2007 | - | $38.42 M(+466.9%) |
| Jun 2007 | - | $6.78 M(-12.3%) |
| Mar 2007 | $7.73 M | $7.73 M(+46.1%) |
| Dec 2006 | - | $5.29 M(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $5.48 M(+2.6%) |
| Jun 2006 | - | $5.34 M(-1.6%) |
| Mar 2006 | $5.43 M(+68.8%) | $5.43 M(+22.1%) |
| Dec 2005 | - | $4.45 M(-24.8%) |
| Sep 2005 | - | $5.91 M(+22.0%) |
| Jun 2005 | - | $4.85 M(+50.7%) |
| Mar 2005 | $3.22 M(-18.7%) | $3.22 M(-3.2%) |
| Dec 2004 | - | $3.32 M(-15.9%) |
| Sep 2004 | - | $3.95 M(-3.7%) |
| Jun 2004 | - | $4.10 M(+3.6%) |
| Mar 2004 | $3.96 M(-35.2%) | $3.96 M(+67.0%) |
| Dec 2003 | - | $2.37 M(-29.6%) |
| Sep 2003 | - | $3.37 M(-77.9%) |
| Jun 2003 | - | $15.25 M(+149.7%) |
| Mar 2003 | $6.11 M(-29.8%) | $6.11 M(+1.4%) |
| Dec 2002 | - | $6.03 M(-37.8%) |
| Sep 2002 | - | $9.68 M(+10.6%) |
| Jun 2002 | - | $8.76 M(+0.7%) |
| Mar 2002 | $8.70 M(-46.2%) | $8.70 M(+52.4%) |
| Dec 2001 | - | $5.71 M(+60.3%) |
| Sep 2001 | - | $3.56 M(-70.5%) |
| Jun 2001 | - | $12.09 M(-25.2%) |
| Mar 2001 | $16.16 M(-35.9%) | $16.16 M(+27.9%) |
| Dec 2000 | - | $12.64 M(-53.8%) |
| Sep 2000 | - | $27.37 M(+5.2%) |
| Jun 2000 | - | $26.01 M(+3.1%) |
| Mar 2000 | $25.23 M(+664.4%) | $25.23 M(+171.3%) |
| Dec 1999 | - | $9.30 M(-14.7%) |
| Sep 1999 | - | $10.90 M(-7.6%) |
| Jun 1999 | - | $11.80 M(+257.6%) |
| Mar 1999 | $3.30 M(-29.8%) | $3.30 M(-10.8%) |
| Dec 1998 | - | $3.70 M(-9.8%) |
| Sep 1998 | - | $4.10 M(-4.7%) |
| Jun 1998 | - | $4.30 M(-8.5%) |
| Mar 1998 | $4.70 M(+34.3%) | $4.70 M(-4.1%) |
| Dec 1997 | - | $4.90 M(+58.1%) |
| Sep 1997 | - | $3.10 M(-11.4%) |
| Jun 1997 | - | $3.50 M(0.0%) |
| Mar 1997 | $3.50 M(-49.3%) | $3.50 M(+6.1%) |
| Dec 1996 | - | $3.30 M(0.0%) |
| Sep 1996 | - | $3.30 M(+6.5%) |
| Jun 1996 | - | $3.10 M(-55.1%) |
| Mar 1996 | $6.90 M(-50.0%) | $6.90 M(-20.7%) |
| Dec 1995 | - | $8.70 M(-23.7%) |
| Sep 1995 | - | $11.40 M(+50.0%) |
| Jun 1995 | - | $7.60 M(-44.9%) |
| Mar 1995 | $13.80 M(-50.2%) | $13.80 M(-23.3%) |
| Dec 1994 | - | $18.00 M(-15.5%) |
| Sep 1994 | - | $21.30 M(-27.6%) |
| Jun 1994 | - | $29.40 M(+6.1%) |
| Mar 1994 | $27.70 M(-9.5%) | $27.70 M(+83.4%) |
| Dec 1993 | - | $15.10 M(-31.4%) |
| Sep 1993 | - | $22.00 M(-14.1%) |
| Jun 1993 | - | $25.60 M(-16.3%) |
| Mar 1993 | $30.60 M(-2.5%) | $30.60 M(+4.1%) |
| Dec 1992 | - | $29.40 M(+0.7%) |
| Sep 1992 | - | $29.20 M(-3.6%) |
| Jun 1992 | - | $30.30 M(-3.5%) |
| Mar 1992 | $31.40 M(+38.9%) | $31.40 M(-22.1%) |
| Dec 1991 | - | $40.30 M(-7.4%) |
| Sep 1991 | - | $43.50 M(-3.8%) |
| Jun 1991 | - | $45.20 M(+100.0%) |
| Mar 1991 | $22.60 M(+29.9%) | $22.60 M(+6.1%) |
| Dec 1990 | - | $21.30 M(-5.8%) |
| Sep 1990 | - | $22.60 M(-8.1%) |
| Jun 1990 | - | $24.60 M(+41.4%) |
| Mar 1990 | $17.40 M(+102.3%) | $17.40 M(+102.3%) |
| Mar 1989 | $8.60 M(+2.4%) | $8.60 M(+2.4%) |
| Mar 1988 | $8.40 M(-53.3%) | $8.40 M(-53.3%) |
| Mar 1987 | $18.00 M(+185.7%) | $18.00 M(+185.7%) |
| Mar 1986 | $6.30 M(+1.6%) | $6.30 M(+1.6%) |
| Mar 1985 | $6.20 M | $6.20 M |
FAQ
- What is Repligen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Repligen?
- What is Repligen annual cash & cash equivalents year-on-year change?
- What is Repligen quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Repligen?
- What is Repligen quarterly cash and cash equivalents year-on-year change?
What is Repligen annual cash & cash equivalents?
The current annual cash & cash equivalents of RGEN is $751.32 M
What is the all time high annual cash & cash equivalents for Repligen?
Repligen all-time high annual cash & cash equivalents is $751.32 M
What is Repligen annual cash & cash equivalents year-on-year change?
Over the past year, RGEN annual cash & cash equivalents has changed by +$227.87 M (+43.53%)
What is Repligen quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RGEN is $783.96 M
What is the all time high quarterly cash and cash equivalents for Repligen?
Repligen all-time high quarterly cash and cash equivalents is $809.15 M
What is Repligen quarterly cash and cash equivalents year-on-year change?
Over the past year, RGEN quarterly cash and cash equivalents has changed by +$153.19 M (+24.29%)